drugset
drugset / Trial / NCT04673877

Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration

NCT04673877 ↗

Phase 1 Completed 20 enrolled Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).

Timeline

Start
2021-08-26
Primary completion
2022-08-17
Completion
2022-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 500 mg Intravenous
Subject Vancomycin Other / unclassified 1 g Intravenous

Indications

infectious disease